I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

XERS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.56%

Insider Buying (Last 12 Months): $90,249.61

Insider Selling (Last 12 Months): $0.00

Xeris Biopharma Insider Trading History Chart

Xeris Biopharma Share Price & Price History

^$3.23

▲ +0.01 (0.31%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Xeris Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2024	John P Schmid	Director	Buy	4,285	$2.37	$10,155.45	20,685
3/14/2024	John P Schmid	Director	Buy	4,500	$2.16	$9,720.00	11,000
11/27/2023	Jeffrey W Sherman	Director	Buy	5,400	$1.87	$10,098.00	5,400
11/17/2023	John Patrick Shannon Jr	Insider	Buy	30,769	$1.64	$50,461.16	1,408,575
11/16/2023	John P Schmid	Director	Buy	6,500	$1.51	$9,815.00	6,500
8/9/2023	Paul R. Edick	Insider	Buy	10,000	$2.38	$23,800.00	2,288,064
5/12/2022	Paul R. Edick	Insider	Buy	100,000	$1.40	$140,000.00	1,508,064
2/22/2022	Steven Prestrelski	Insider	Sell	11,228	$2.42	$27,171.76
11/15/2021	Paul R. Edick	Insider	Buy	20,000	$2.28	$45,600.00

Musk Says ‘Dollar Will Be Worth Nothing…’

From Crypto 101 Media | Ad

Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…

All you have to do is claim your free ticket to the event now…

SEC Filings (Institutional Ownership Changes) for Xeris Biopharma (NASDAQ:XERS)

42.75% of Xeris Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Xeris Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/30/2024	Rosalind Advisors Inc.	3,104,995	$8.85M	5.6%	-0.5%	2.094%
10/30/2024	Stoneridge Investment Partners LLC	15,028	$43K	0.0%	-71.8%	0.010%
10/25/2024	China Universal Asset Management Co. Ltd.	28,657	$82K	0.0%	+64.5%	0.019%
10/24/2024	Goldstein Advisors LLC	30,425	$87K	0.0%	+19.7%	0.020%
10/24/2024	Wealth Enhancement Advisory Services LLC	12,421	$35K	0.0%	N/A	0.008%
10/8/2024	CWM LLC	34,167	$97K	0.0%	+93.7%	0.023%
10/3/2024	SG Americas Securities LLC	60,202	$0.17M	0.0%	+188.5%	0.041%
9/5/2024	Sanctuary Advisors LLC	33,429	$75K	0.0%	N/A	0.023%
8/15/2024	The Manufacturers Life Insurance Company	57,805	$0.13M	0.0%	+10.1%	0.039%
8/15/2024	AQR Capital Management LLC	1,193,080	$2.68M	0.0%	+4.6%	0.805%
8/14/2024	ProShare Advisors LLC	26,974	$61K	0.0%	-19.7%	0.018%
8/13/2024	Asset Management Group Inc.	26,480	$60K	0.0%	+130.7%	0.018%
8/12/2024	XTX Topco Ltd	31,782	$72K	0.0%	-87.5%	0.021%
8/9/2024	Renaissance Technologies LLC	1,351,640	$3.04M	0.0%	+33.9%	0.912%
8/9/2024	Dimensional Fund Advisors LP	48,663	$0.11M	0.0%	-11.7%	0.033%
8/9/2024	Thompson Siegel & Walmsley LLC	172,784	$0.39M	0.0%	-9.1%	0.117%
8/1/2024	Rhumbline Advisers	189,970	$0.43M	0.0%	+6.9%	0.128%
7/29/2024	Principal Financial Group Inc.	78,626	$0.18M	0.0%	-12.3%	0.053%
7/26/2024	Allspring Global Investments Holdings LLC	16,282	$37K	0.0%	+4,512.5%	0.011%
7/26/2024	Bank of New York Mellon Corp	428,554	$0.96M	0.0%	+23.0%	0.289%
7/16/2024	Deltec Asset Management LLC	14,000	$32K	0.0%	-73.1%	0.009%
7/12/2024	Rosalind Advisors Inc.	3,120,170	$7.02M	5.1%	+10.6%	2.105%
7/10/2024	Simplicity Wealth LLC	12,156	$27K	0.0%	N/A	0.008%
5/16/2024	California State Teachers Retirement System	13,380	$30K	0.0%	-38.9%	0.009%
5/16/2024	Invenomic Capital Management LP	604,512	$1.34M	0.1%	+6.3%	0.408%
5/16/2024	Bayesian Capital Management LP	16,732	$37K	0.0%	N/A	0.011%
5/15/2024	NEA Management Company LLC	419,100	$0.93M	0.1%	N/A	0.283%
5/15/2024	Price T Rowe Associates Inc. MD	125,635	$0.28M	0.0%	+9.2%	0.085%
5/15/2024	Alpine Global Management LLC	300,000	$0.66M	0.2%	+11.1%	0.202%
5/10/2024	Vanguard Group Inc.	7,606,242	$16.81M	0.0%	+7.3%	5.131%
5/7/2024	SG Americas Securities LLC	21,017	$46K	0.0%	-37.8%	0.014%
4/29/2024	Principal Financial Group Inc.	89,618	$0.20M	0.0%	+100.4%	0.060%
4/29/2024	China Universal Asset Management Co. Ltd.	26,516	$59K	0.0%	+66.0%	0.018%
4/25/2024	Rosalind Advisors Inc.	2,820,170	$6.23M	5.8%	-20.4%	2.008%
4/18/2024	Diversified Trust Co	175,741	$0.39M	0.0%	+12.9%	0.125%
4/17/2024	Deltec Asset Management LLC	52,000	$0.12M	0.0%	-79.9%	0.037%
2/20/2024	Quarry LP	20,000	$47K	0.0%	N/A	0.014%
2/14/2024	Invenomic Capital Management LP	568,619	$1.34M	0.1%	N/A	0.412%
2/14/2024	CenterBook Partners LP	110,627	$0.26M	0.0%	N/A	0.080%
2/13/2024	Stonepine Capital Management LLC	5,937,000	$13.95M	6.0%	+0.4%	4.298%
2/13/2024	Tower Research Capital LLC TRC	27,848	$65K	0.0%	+53.7%	0.020%
2/12/2024	Eagle Asset Management Inc.	20,423	$48K	0.0%	N/A	0.015%
2/8/2024	Brown Advisory Inc.	211,405	$0.50M	0.0%	-7.9%	0.153%
2/8/2024	Panagora Asset Management Inc.	140,318	$0.33M	0.0%	-43.9%	0.102%
1/24/2024	China Universal Asset Management Co. Ltd.	15,973	$38K	0.0%	+351.1%	0.012%
1/22/2024	Deltec Asset Management LLC	259,246	$0.61M	0.1%	-17.8%	0.188%
1/12/2024	SG Americas Securities LLC	33,777	$79K	0.0%	+83.9%	0.024%
1/8/2024	Diversified Trust Co	155,650	$0.37M	0.0%	-11.3%	0.113%
11/15/2023	Annandale Capital LLC	25,000	$47K	0.0%	N/A	0.018%
11/15/2023	GSA Capital Partners LLP	381,231	$0.71M	0.1%	+1,047.8%	0.276%
11/14/2023	MPM Bioimpact LLC	3,987,967	$7.42M	2.0%	+0.3%	2.888%
11/14/2023	Alpine Global Management LLC	300,000	$0.56M	0.1%	+33.3%	0.217%
11/14/2023	Stonepine Capital Management LLC	5,915,372	$11M	3.7%	+7.5%	4.284%
11/7/2023	Barclays PLC	105,743	$0.20M	0.0%	+14.1%	0.077%
10/31/2023	Panagora Asset Management Inc.	250,200	$0.47M	0.0%	-13.0%	0.181%
10/25/2023	Brown Advisory Inc.	229,505	$0.43M	0.0%	-2.9%	0.166%
10/24/2023	Bank of New York Mellon Corp	412,943	$0.77M	0.0%	-2.7%	0.299%
10/24/2023	Cambridge Investment Research Advisors Inc.	35,670	$66K	0.0%	N/A	0.026%
10/23/2023	Deltec Asset Management LLC	315,246	$0.59M	0.1%	-22.4%	0.228%
10/13/2023	SG Americas Securities LLC	18,363	$34K	0.0%	N/A	0.013%
10/10/2023	Sinecera Capital LLC	253,101	$0.47M	0.6%	N/A	0.183%
8/15/2023	Caxton Corp	5,641,920	$14.78M	42.7%	-6.6%	4.086%
8/11/2023	Panagora Asset Management Inc.	287,600	$0.75M	0.0%	N/A	0.212%
8/10/2023	Cetera Advisor Networks LLC	110,837	$0.29M	0.0%	+6.3%	0.082%
8/7/2023	Principal Financial Group Inc.	45,290	$0.12M	0.0%	+202.6%	0.033%
8/3/2023	Mackenzie Financial Corp	25,978	$66K	0.0%	N/A	0.019%
7/31/2023	Strs Ohio	64,300	$0.17M	0.0%	N/A	0.047%
7/27/2023	Virtu Financial LLC	80,416	$0.21M	0.0%	+155.3%	0.059%
7/21/2023	Creative Planning	11,393	$30K	0.0%	N/A	0.008%
7/18/2023	Diversified Trust Co	175,407	$0.46M	0.0%	+12.7%	0.129%
7/18/2023	Deltec Asset Management LLC	406,190	$1.06M	0.2%	-34.7%	0.300%
5/15/2023	Rubric Capital Management LP	426,267	$0.70M	0.0%	N/A	0.315%
5/15/2023	Stonepine Capital Management LLC	8,640,205	$14.08M	4.7%	-22.8%	6.375%
5/9/2023	Goldstein Advisors LLC	25,425	$41K	0.0%	+64.8%	0.019%
5/1/2023	Virtu Financial LLC	31,498	$51K	0.0%	N/A	0.023%
4/28/2023	Van Hulzen Asset Management LLC	20,278	$33K	0.0%	N/A	0.015%
4/28/2023	SG Americas Securities LLC	40,947	$67K	0.0%	N/A	0.030%
4/17/2023	Deltec Asset Management LLC	622,072	$1.01M	0.3%	+68.6%	0.459%
3/23/2023	MetLife Investment Management LLC	25,829	$34K	0.0%	-63.5%	0.019%
1/25/2023	Deltec Asset Management LLC	368,926	$0.49M	0.1%	-31.4%	0.272%
11/15/2022	Kamunting Street Capital Management L.P.	75,000	$0.12M	0.2%	N/A	0.055%
11/14/2022	Armistice Capital LLC	2,504,431	$3.91M	0.1%	-57.0%	1.848%
11/10/2022	Stonepine Capital Management LLC	12,928,168	$20.17M	9.1%	+11.0%	9.539%
11/10/2022	ExodusPoint Capital Management LP	20,528	$32K	0.0%	-63.9%	0.015%
11/7/2022	Virtu Financial LLC	18,180	$28K	0.0%	-67.9%	0.013%
11/3/2022	Barclays PLC	60,745	$95K	0.0%	+105.3%	0.045%
10/31/2022	SG Americas Securities LLC	25,397	$40K	0.0%	N/A	0.019%
10/26/2022	Deltec Asset Management LLC	537,926	$0.84M	0.2%	+32.5%	0.397%
10/18/2022	Bailard Inc.	56,000	$87K	0.0%	N/A	0.041%
8/15/2022	Laurion Capital Management LP	20,756	$32K	0.0%	N/A	0.015%
8/11/2022	Yakira Capital Management Inc.	90,076	$0.14M	0.0%	-23.1%	0.066%
8/3/2022	AE Wealth Management LLC	79,787	$0.12M	0.0%	N/A	0.059%
8/1/2022	ProShare Advisors LLC	25,428	$39K	0.0%	+81.8%	0.019%
7/27/2022	Sinecera Capital LLC	253,101	$0.39M	0.4%	N/A	0.187%
7/19/2022	GPS Wealth Strategies Group LLC	65,025	$100K	0.0%	N/A	0.048%
7/18/2022	Deltec Asset Management LLC	406,000	$0.63M	0.1%	+63.7%	0.300%
5/16/2022	Granahan Investment Management LLC	405,247	$1.04M	0.0%	-22.8%	0.609%
5/12/2022	Yakira Capital Management Inc.	117,076	$0.30M	0.0%	N/A	0.176%
5/12/2022	Running Point Capital Advisors LLC	10,000	$26K	0.0%	N/A	0.015%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	28,897	$74K	0.0%	N/A	0.043%

Data available starting January 2016

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Today's Range

Now: $3.23

$3.17

$3.29

50 Day Range

MA: $2.91

$2.51

$3.24

52 Week Range

Now: $3.23

$1.46

$3.39

Volume

686,782 shs

Average Volume

1,165,513 shs

Market Capitalization

$481.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.7

Who are the company insiders with the largest holdings of Xeris Biopharma?: Xeris Biopharma's top insider investors include:
Paul R Edick (Insider)
John Patrick Shannon Jr (Insider)
John P Schmid (Director)
Jeffrey W Sherman (Director)
Learn More about top insider investors at Xeris Biopharma.
Who are the major institutional investors of Xeris Biopharma?: Xeris Biopharma's top institutional investors include:
Rosalind Advisors Inc. — 2.09%
SG Americas Securities LLC — 0.04%
CWM LLC — 0.02%
Goldstein Advisors LLC — 0.02%
China Universal Asset Management Co. Ltd. — 0.02%
Stoneridge Investment Partners LLC — 0.01%
Learn More about top institutional investors of Xeris Biopharma stock.
Which major investors are selling Xeris Biopharma stock?: During the last quarter, XERS stock was sold by these institutional investors:
Stoneridge Investment Partners LLC
Rosalind Advisors Inc.
Which major investors are buying Xeris Biopharma stock?: Within the previous quarter, XERS stock was purchased by institutional investors including:
SG Americas Securities LLC
CWM LLC
Wealth Enhancement Advisory Services LLC
China Universal Asset Management Co. Ltd.
Goldstein Advisors LLC
Within the previous year, these company insiders have bought Xeris Biopharma stock:
Paul R Edick (Insider)
John Patrick Shannon Jr (Insider)
John P Schmid (Director)
Jeffrey W Sherman (Director)
Learn More investors buying Xeris Biopharma stock.